Cargando…
Hornerin contains a Linked Series of Ribosome-Targeting Peptide Antibiotics
Cationic intrinsically disordered antimicrobial peptides (CIDAMPs) belong to a novel class of epithelial peptide antibiotics with microbicidal activity against various pathogens, including Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus and Candida albicans. Here we show that treatme...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212518/ https://www.ncbi.nlm.nih.gov/pubmed/30385807 http://dx.doi.org/10.1038/s41598-018-34467-8 |
_version_ | 1783367555959750656 |
---|---|
author | Gerstel, Ulrich Latendorf, Ties Bartels, Joachim Becker, Alexander Tholey, Andreas Schröder, Jens-Michael |
author_facet | Gerstel, Ulrich Latendorf, Ties Bartels, Joachim Becker, Alexander Tholey, Andreas Schröder, Jens-Michael |
author_sort | Gerstel, Ulrich |
collection | PubMed |
description | Cationic intrinsically disordered antimicrobial peptides (CIDAMPs) belong to a novel class of epithelial peptide antibiotics with microbicidal activity against various pathogens, including Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus and Candida albicans. Here we show that treatment of distinct bacteria with different hornerin (HRNR)-derived CIDAMPs cause formation of unique cytoplasmic protein aggregates, suggesting a common intracellular mode of action. We further found that, unlike most amphipathic antimicrobial peptides, HRNR traverses bacterial membranes energy-dependently and accumulates within the cytoplasm. Strikingly, certain structurally different, HRNR-based CIDAMPs were found to bind to an identical panel of distinct bacterial ribosomal proteins, thereby manifesting features of several known classes of antibiotics. This may cause the formation of aberrant proteins and toxic protein aggregates in HRNR-treated pathogens which eventually may induce its death. Our study reveals evidence that structurally distinct CIDAMPs of an abundant body surface protein simultaneously target multiple sites of the bacterial protein synthesis machinery. |
format | Online Article Text |
id | pubmed-6212518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-62125182018-11-06 Hornerin contains a Linked Series of Ribosome-Targeting Peptide Antibiotics Gerstel, Ulrich Latendorf, Ties Bartels, Joachim Becker, Alexander Tholey, Andreas Schröder, Jens-Michael Sci Rep Article Cationic intrinsically disordered antimicrobial peptides (CIDAMPs) belong to a novel class of epithelial peptide antibiotics with microbicidal activity against various pathogens, including Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus and Candida albicans. Here we show that treatment of distinct bacteria with different hornerin (HRNR)-derived CIDAMPs cause formation of unique cytoplasmic protein aggregates, suggesting a common intracellular mode of action. We further found that, unlike most amphipathic antimicrobial peptides, HRNR traverses bacterial membranes energy-dependently and accumulates within the cytoplasm. Strikingly, certain structurally different, HRNR-based CIDAMPs were found to bind to an identical panel of distinct bacterial ribosomal proteins, thereby manifesting features of several known classes of antibiotics. This may cause the formation of aberrant proteins and toxic protein aggregates in HRNR-treated pathogens which eventually may induce its death. Our study reveals evidence that structurally distinct CIDAMPs of an abundant body surface protein simultaneously target multiple sites of the bacterial protein synthesis machinery. Nature Publishing Group UK 2018-11-01 /pmc/articles/PMC6212518/ /pubmed/30385807 http://dx.doi.org/10.1038/s41598-018-34467-8 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Gerstel, Ulrich Latendorf, Ties Bartels, Joachim Becker, Alexander Tholey, Andreas Schröder, Jens-Michael Hornerin contains a Linked Series of Ribosome-Targeting Peptide Antibiotics |
title | Hornerin contains a Linked Series of Ribosome-Targeting Peptide Antibiotics |
title_full | Hornerin contains a Linked Series of Ribosome-Targeting Peptide Antibiotics |
title_fullStr | Hornerin contains a Linked Series of Ribosome-Targeting Peptide Antibiotics |
title_full_unstemmed | Hornerin contains a Linked Series of Ribosome-Targeting Peptide Antibiotics |
title_short | Hornerin contains a Linked Series of Ribosome-Targeting Peptide Antibiotics |
title_sort | hornerin contains a linked series of ribosome-targeting peptide antibiotics |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212518/ https://www.ncbi.nlm.nih.gov/pubmed/30385807 http://dx.doi.org/10.1038/s41598-018-34467-8 |
work_keys_str_mv | AT gerstelulrich hornerincontainsalinkedseriesofribosometargetingpeptideantibiotics AT latendorfties hornerincontainsalinkedseriesofribosometargetingpeptideantibiotics AT bartelsjoachim hornerincontainsalinkedseriesofribosometargetingpeptideantibiotics AT beckeralexander hornerincontainsalinkedseriesofribosometargetingpeptideantibiotics AT tholeyandreas hornerincontainsalinkedseriesofribosometargetingpeptideantibiotics AT schroderjensmichael hornerincontainsalinkedseriesofribosometargetingpeptideantibiotics |